We are live on ! Find out more
Baillie Gifford & Co

Baillie Gifford & Co Portfolio holdings

AUM $110B
1-Year Est. Return 4.8%
 

Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.

This Fund
S&P 500
This Quarter Est. Return
+19.56%
1 Year Est. Return
+4.8%
3 Year Est. Return
+123.53%
5 Year Est. Return
+125.55%
10 Year Est. Return
+1,754.37%
AUM
$126B
AUM Growth
+$16.6B
Cap. Flow
-$1.76B
Cap. Flow %
-1.4%
Top 10 Hldgs %
40.55%
Holding
303
New
14
Increased
69
Reduced
196
Closed
15

Top Sells

Rank Stock Value
1
MELI icon
Mercado Libre
MELI
+$919M
2
TSLA icon
Tesla
TSLA
+$857M
3
ILMN icon
Illumina
ILMN
+$616M
4
TTD icon
Trade Desk
TTD
+$273M
5
NFLX icon
Netflix
NFLX
+$211M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 29.23%
2 Technology 27.33%
3 Healthcare 14.71%
4 Communication Services 12.31%
5 Financials 6.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLLS
251
Cellectis
CLLS
$285M
$2.52M ﹤0.01%
816,643
-347,366
-30% -$824K
AKLI
252
DELISTED
Akili Inc
AKLI
$2.19M ﹤0.01%
4,665,795
COIN icon
253
Coinbase
COIN
$40.5B
$1.87M ﹤0.01%
10,778
-2,100
-16% -$229K
SAGE
254
DELISTED
Sage Therapeutics
SAGE
$1.84M ﹤0.01%
84,765
-3,742
-4% -$74.2K
GOOS
255
Canada Goose Holdings
GOOS
$856M
$1.41M ﹤0.01%
119,221
-23,479
-16% -$278K
LYEL icon
256
Lyell Immunopharma
LYEL
$360M
$1.34M ﹤0.01%
34,544
-2,088
-6% -$75.2K
NOVT icon
257
Novanta
NOVT
$6.29B
$1.31M ﹤0.01%
7,765
-80
-1% -$11.7K
BCE icon
258
BCE
BCE
$21.2B
$1.24M ﹤0.01%
31,257
+747
+2% +$28.9K
VRNS icon
259
Varonis Systems
VRNS
$5B
$1.2M ﹤0.01%
26,514
-268
-1% -$10.1K
NCNA
260
NuCana
NCNA
$6.12M
$1.08M ﹤0.01%
732
ED icon
261
Consolidated Edison
ED
$39.9B
$1.06M ﹤0.01%
11,628
+4,748
+69% +$424K
AEE icon
262
Ameren
AEE
$30.1B
$1.01M ﹤0.01%
13,935
+6,263
+82% +$476K
SPIR icon
263
Spire Global
SPIR
$555M
$847K ﹤0.01%
108,255
EQR icon
264
Equity Residential
EQR
$25.1B
$807K ﹤0.01%
13,200
+3,300
+33% +$191K
CARG icon
265
CarGurus
CARG
$3.47B
$755K ﹤0.01%
31,258
-301
-1% -$6.05K
XNCR icon
266
Xencor
XNCR
$1.55B
$658K ﹤0.01%
31,005
-313
-1% -$5.96K
BIRD icon
267
Smartbird Inc
BIRD
$22.3M
$652K ﹤0.01%
26,625
DLR icon
268
Digital Realty Trust
DLR
$71.7B
$645K ﹤0.01%
4,796
+473
+11% +$61.1K
DOC
269
DELISTED
PHYSICIANS REALTY TRUST
DOC
$588K ﹤0.01%
44,143
+4,715
+12% +$56K
CALX icon
270
Calix
CALX
$2.39B
$563K ﹤0.01%
12,896
-123
-0.9% -$4.92K
MTLS
271
Materialise
MTLS
$396M
$546K ﹤0.01%
83,119
-56,376
-40% -$333K
HR icon
272
Healthcare Realty
HR
$6.84B
$529K ﹤0.01%
30,694
+3,647
+13% +$55.7K
BAND
273
Bandwidth Inc
BAND
$1.61B
$430K ﹤0.01%
29,690
-307
-1% -$3.58K
LAW icon
274
CS Disco
LAW
$279M
$277K ﹤0.01%
36,460
-362
-1% -$2.28K
RDFN
275
DELISTED
Redfin
RDFN
$225K ﹤0.01%
21,792
-8,673,546
-100% -$60.4M

Similar funds

Baillie Gifford & Co's Q4 2023 Portfolio in Review

As of Q4 2023, Baillie Gifford & Co held 303 positions worth $126B, up 15% from $110B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Baillie Gifford & Co's Q4 2023 filing shows 14 new, 69 increased, 196 reduced and 15 closed positions. Its largest new stake was Insulet: 1,212,759 shares worth $263M. The largest sale was Mercado Libre, an estimated $919M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 29% of assets, down from 30% a quarter earlier, followed by Technology and Healthcare.

  • Baillie Gifford & Co's largest Q4 2023 buy was Insulet: 1,212,759 shares worth $263M.
  • Baillie Gifford & Co added most to Enphase Energy in Q4 2023, an estimated $433M increase.
  • Baillie Gifford & Co's biggest Q4 2023 reduction was Mercado Libre, cutting an estimated $919M.
  • Baillie Gifford & Co fully exited Abcam PLC in Q4 2023, selling an estimated $165M.
  • Baillie Gifford & Co's ten largest holdings make up 41% of its $126B portfolio in Q4 2023.
  • Baillie Gifford & Co opened 14 new positions and closed 15 in Q4 2023.
  • Baillie Gifford & Co's portfolio value rose 15% quarter-over-quarter to $126B.

Based on Baillie Gifford & Co's 13F filing for Q4 2023, filed 26 Jan 2024.